KDM2B and mantle cell lymphoma: In addition, we found that MCL patients that express high FGFR1 protein levels have higher expression of both KDM2B and EZH2 and lower levels of CDKN1C, as opposed to MCL patients expressing low FGFR1 (Fig. 4E).